Emergent BioSolutions Inc. (NYSE:EBS) is seeking M&A. Robert G. Kramer President and Chief Executive Officer said during the Third Quarter 2021 Financial Results Conference Call, "Our third quarter operational results demonstrate that our business remains resilient and poised for growth in line with our strategy. We continue on our path of both organic opportunities and potential M&A informed by prudent capital deployment, all aimed at generating enhanced shareholder value".
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.3 USD | +70.98% | +51.38% | +37.50% |
05-02 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
05-02 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.50% | 101M | |
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+17.65% | 326B | |
+3.77% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.79% | 154B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Emergent BioSolutions Seeks M&A